Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05123716 · ClinicalTrials.gov registry record · Early Phase 1
Drug Effects on Interpersonal Interaction
A Early Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
NCT05123716 is a Early Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 30 participants.
The verdict
NCT05123716, a Early Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
The investigators propose to use a Paired Partner design, in which subjects engage in a 45-min semi-structured conversation with one (novel) partner under the influence of MDMA and with another partner under the influence of placebo. At the end of each session, they will rate their feelings about the partner, and on the test day, subjects will be asked which partner they preferred and felt closer to.
Interventions
- DRUG MDMA
- DRUG placebo oral tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-08-01 |
| Est. Completion | 2022-05-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05123716
The ClinicalTrials.gov registry entry for NCT05123716 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which MDMA is the first listed.
NCT05123716 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05123716 about?
NCT05123716 is a clinical study titled "Drug Effects on Interpersonal Interaction". The investigators propose to use a Paired Partner design, in which subjects engage in a 45-min semi-structured conversation with one (novel) partner under the influence of MDMA and with another partner under the influence of placebo. At the end of each session, they will rate their feelings about th...
What is the current status of trial NCT05123716?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2021-08-01. Estimated completion is 2022-05-01.
What interventions are being tested in trial NCT05123716?
The interventions under investigation include: MDMA (DRUG), placebo oral tablet (DRUG).
Who is sponsoring clinical trial NCT05123716?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.